Teva Relief Rally Loses Steam After Analyst Downgrade
Teva Pharmaceutical shares moved lower after Morgan Stanley downgraded the stock to Underweight with a price target of $6 per share.
Teva Pharmaceutical shares moved lower after Morgan Stanley downgraded the stock to Underweight with a price target of $6 per share.